Clinical Trials Browser

Phase 1/2 × Glioblastoma × liposomal doxorubicin × Clear all

NCT00944801 2009-07-23

Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma

Phase 1/2 Completed

Glioblastoma